Binding method for detection of muscarinic acetylcholine receptors in receptor’s natural environment

Neuromethods

Volumn 107, Issue , 2016, Pages 69-81

  Muramatsu, Ikunobu ^a   Yoshiki, Hatsumi ^a   Sada, Kiyonao ^a   Uwada, Junsuke ^a   Taniguchi, Takanobu ^a   Masuoka, Takayoshi ^a   Nishio, Matomo ^a  

^a NONE

Author keywords

Affinity and density; Muscarinic acetylcholine receptor (mAChR); Natural tissue environment; Radioligand binding; Subcellular distribution; Tissue homogenates; Tissue segments

Indexed keywords

ATROPINE; MUSCARINIC RECEPTOR; RADIOLIGAND;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; BLADDER; BRAIN CORTEX; CELL SURFACE; CELLULAR DISTRIBUTION; DETRUSOR MUSCLE; DISSOCIATION CONSTANT; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RECEPTOR BINDING ASSAY; SOLUBILIZATION; TISSUE PREPARATION;

EID: 84938818202     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2858-3_4     Document Type: Article

References (36)

1. Yamamura HI, Enna SJ, Kuhar MJ (eds) (1985) Neurotransmitter receptor binding, 2nd edn. Raven Press, New York
2. Bylund DB, Deupree JD, Toews ML (2004) Radioligand-binding methods for membrane preparations and intact cells. Methods Mol Biol 259:1–28
3. Paton WDM, Rang HP (1965) The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors. Proc R Soc Lond B Biol Sci 163:1–44
4. Alexander SPH, Mathie A, Peters JA (2009) Guide to Receptors and Channels (GRAC), 4th edition. Br J Pharmacol 158(suppl):S1–S254
5. Kenakin T (1995) On the importance of the “antagonist assumption” to how receptors express themselves. Biochem Pharmacol 55:17–26
6. Kenakin T, Miller LJ (2010) Seven transmembrane receptors as shape shifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 62:265–304
7. Muramatsu I, Tanaka T, Suzuki F, Li Z, Hiraizumi-Hiraoka Y, Anisuzzaman ASM, Yamamoto H, Horinouchi T, Morishima S (2005) Quantifying receptor properties: the tissue segment binding method—a powerful tool for the pharmacome analysis of native receptors. J Pharmacol Sci 98:331–339
8. Baker JG, Hill SJ (2007) Multiple GPCR conformations and signaling pathways: implications for antagonist affi nity estimates. Trends Pharmacol Sci 28:374–381
9. Nelson CP, Challiss RAJ (2007) “Phenotypic” pharmacology: the infl uence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem Pharmacol 73:737–751
10. Lane JR, Sexton PM, Christopoulos A (2013) Bridging the gap: bitopic ligands of G-proteincoupled receptors. Trends Pharmacol Sci 34:59–66
11. Toung MDT, Garbarg M, Schwartz JC (1980) Pharmacological specifi city of brain histamine H2-receptors differs in intact cells and cell-free preparations. Nature 287:548–551
12. Nishimune A, Yoshiki H, Uwada J, Anisuzzaman AS, Umada H, Muramatsu I (2012) Phenotype Pharmacology of lower urinary tract α 1 -adrenoceptors. Br J Pharmacol 165:1226–1234
13. Yoshiki H, Uwada J, Anisuzzaman ASM, Umada H, Hayashi R, Kainoh M, Masuoka T, Nishio M, Muramatsu I (2014) Pharmacologically distinct phenotypes of α 1B - adrenoceptors: variation in binding and functional affi nities for antagonists. Br J Pharmacol 171:4890–4901
14. Anisuzzaman ASM, Nishimune A, Yoshiki H, Uwada J, Muramatsu I (2011) Infl uence of tissue integrity of pharmacological phenotypes of muscarinic acetylcholine receptors in the rat cerebral cortex. J Pharmacol Exp Ther 339: 186–193
15. Boxall DK, Ford AP, Choppin A, Nahorski SR, Challis RA, Eglen RM (1998) Characterization of an atypical muscarinic cholinoceptor mediating contraction of the guinea-pig isolated uterus. Br J Pharmacol 124:1615–1622
16. Munns M, Pennefather JN (1998) Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats. Br J Pharmacol 123:1639–1644
17. Uwada J, Anisuzzaman AMS, Yoshiki H, Nishimune A, Muramatsu I (2011) Intracellular distribution of functional M1-muscarinic acetylcholine receptors in N1E-115 neuroblastoma cells. J Neurochem 118:958–967
18. Anisuzzaman AMS, Uwada J, Masuoka T, Yoshiki H, Nishio M, Ikegaya Y, Takahashi N, Matsuki N, Fujibayashi Y, Yonekura Y, Momiyama T, Muramatsu I (2013) Novel contribution of cell surface and intracellular M1-muscarinic acetylcholine receptors to synaptic plasticity in hippocampus. J Neurochem 126:360–371
19. Tanaka T, Zhang L, Suzuki F, Muramatsu I (2004) Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane binding. Br J Pharmacol 141:468–476
20. Galper JB, Dziekan LC, O’Hara DS, Smith TW (1982) The biphasic response of muscarinic receptors in cultured heart cells to agonists. Effects on receptor number and affi nity in intact cells and homogenates. J Biol Chem 257:10344–10356
21. Koenig JA, Edwardson JM (1996) Intracellular traffi cking of the muscarinic acetylcholine receptor: importance of subtype and cell type. Mol Pharmacol 49:351–359
22. Dessy C, Kelly RA, Balligand JL, Feron O (2000) Dynamic mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J 19:4272–4280
23. Anisuzzaman ASM, Morishima S, Suzuki F, Tanaka T, Yoshiki H, Sathi ZS, Akino H, Yokoyama O, Muramatsu I (2008) Assessment of muscarinic receptor subtypes in human and rat lower urinary tract by tissue segment binding assay. J Pharmacol Sci 106:271–279
24. Uwada J, Yoshiki H, Masuoka T, Nishio M, Muramatsu I (2014) Intracellular localization of M1 muscarinic acetylcholine receptor through clathrin-dependent constitutive internalization via a C-terminal tryptophan-based motif. J Cell Sci 127:3131–3140
25. Van Koppen CJ, Kaiser B (2003) Regulation of muscarinic acetylcholine receptor signaling. Pharmacol Ther 98:197–220
26. Anisuzzaman ASM, Morishima S, Suzuki F, Tanaka T, Muramatsu I (2008) Identifi cation of M1 muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors. Eur J Pharmacol 599:146–151
27. Ikeda T, Anisuzzaman AMS, Yoshiki H, Sasaki M, Koshiji T, Nishimune A, Muramatsu I (2012) Regional quantifi cation of muscarinic acetylcholine receptors and β-adrenoceptors in human airway. Br J Pharmacol 166:1804–1814
28. Khan RIM, Anisuzzaman AMS, Semba S, Ma Y, Uwada J et al (2013) M1 is a major subtype of muscarinic acetylcholine receptors on mouse epithelial cells. J Gastroenterol 48:885–896
29. Wang MH, Yoshiki H, Anisuzzaman ASM, Uwada J, Nishimune A, Lee KS, Taniguchi T, Muramatsu I (2011) Re-evaluation of nicotinic acetylcholine receptors in rat brain by a tissuesegment binding assay. Front Pharmacol 2:65. doi: 10.3389/fphar.2011.00065
30. Colucci WS, Gimbrone JRMA, Alexander RW (1981) Regulation of the postsynaptic alphaadrenergic receptor in rat mesenteric artery. Effects of chemical sympathectomy and epinephrine treatment. Circ Res 48:104–111
31. Faber JE, Yang N, Xin XH (2001) Expression of a-adrenoceptor subtypes by smooth muscle cell and adventitial fi broblast in rat aorta and in cell culture. J Pharmacol Exp Ther 298:441–452
32. Hiraizumi-Hiraoka Y, Tanaka T, Yamamoto H, Suzuki F, Muramatsu I (2004) Identifi cation of alpha-1L adrenoceptor in rabbit ear artery. J Pharmacol Exp Ther 310:995–1002
33. Horinouchi T, Morishima S, Tanaka T, Suzuki F, Tanaka Y, Kioke K, Muramatsu I (2006) Pharmacological evaluation of plasma membrane β-adrenoceptors in rat hearts using the tissue segment binding method. Life Sci 79: 941–948
34. Delmendo RE, Michel AD, Whiting RL (1989) Affi nity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites. Br J Pharmacol 96:457–464
35. Ehlert FJ, Tran LP (1990) Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. J Pharmacol Exp Ther 255:1148–1157
36. Sathi ZS, Anisuzzaman ASM, Morishima S, Suzuki F, Tanaka T, Yoshiki H, Muramatsu I (2008) Different affi nities of native α1Badrenoceptors for ketanserin between intact tissue segments and membrane preparation. Eur J Pharmacol 584:22–228